Table 2 Medical outcome of therapeutic errors Associated with Diabetes medications as the primary substance reported to United States Poison Centers by Medication Category, national poison Data System 2000–2021
From: Therapeutic errors involving diabetes medications reported to United States poison centers
Medication categories | Medical outcome | Total n (%)d | |||||||
|---|---|---|---|---|---|---|---|---|---|
No effect n (%)d | Minor effect n (%)d | Moderate effect n (%)d | Major effect n (%)d | Death n (%)d | Serious medical outcomea n (%)d | Not followedb n (%)d | Unable to followc n | ||
Insulin | 34,228 (59.7) | 4,077 (44.7) | 9,122 (66.5) | 215 (44.2) | 2 (11.9) | 9,339 (65.7) | 16,776 (26.6) | 9,423 | 73,843 (46.8) |
Metformin | 9,938 (17.3) | 2,579 (28.3) | 885 (6.4) | 49 (10.1) | 10 (58.8) | 944 (6.6) | 30,867 (49.0) | 1,147 | 45,475 (28.9) |
Sulfonylureas | 7,985 (13.9) | 1,437 (15.8) | 3,140 (22.9) | 194 (39.9) | 4 (23.5) | 3,338 (23.5) | 6,162 (9.8) | 2,727 | 21,649 (13.7) |
GLP-1 receptor agonists | 774 (1.3) | 402 (4.4) | 143 (1.0) | 7 (1.4) | 0 (0.0) | 150 (1.1) | 1,779 (2.8) | 159 | 3,264 (2.1) |
Other | 4,420 (7.7) | 619 (6.8) | 432 (3.1) | 21 (4.3) | 1 (5.9) | 454 (3.2) | 7,413 (11.8) | 486 | 13,392 (8.5) |
Total (Row%)e | 57,345 (39.9) | 9,114 (6.3) | 13,722 (9.6) | 486 (0.3) | 17 (0.0) | 14,225 (9.9) | 62,997 (43.8) | 13,942 | 157,623 (100.0) |